Investor Directory

We invest in early-stage software companies disrupting the enterprise.

We invest into early-stage startups aiming to address critical issues and inconveniences at scale. We have no investment mandates and are open to most opportunities though we have stringent investment guidelines to maintain focus and discipline.

We invest in proptech startups in the US and globally across stages

We invest in disruptive innovation

TTV's fifth fintech fund..

Forerunner's fourth fund..

We invest in Travel & Tourism Tech startups in Europe & Israel at Seed & Series A stage. We believe that Travel & Tourism is entering a new cycle of changes and that technology and sustainability will be the key drivers of opportunities and outperformance. We detect, select, and enable the future winners providing our investors with the highest returns.

We invest in impactful consumer technology companies

We invest in potential for globally impactful life-science innovation.

I invest in life sciences tools, services, and biopharma services companies. Stage: commercial and pre-commercial stage companies with proven market need for the company’s products or services.

Greycroft's seventh fund..

We invest in Fintech, EdTech, HealthTech, Biotech (platform only), AgTech, CleanTech, and ClimaTech companies.

We invest in Consumer, Fintech and SaaS at early-stage.

We invest in AI B2B software companies in North America, leveraging first access to Founder Institute global AI B2B portfolio ($270M+ raised since 2021) and our exclusive nearshore AI talent community.

We invest in in transformative early-stage technology startups creating a more sustainable, resilient, and connected future. We are a venture capital syndicate that deploys capital to startups charting the future in the following sectors: mobility, climate, internet of things, proptech, security, with a technical focus on software, robotics, and artificial intelligence. To maximize impact, futureland ventures generally invests at the pre-seed or seed stage of a company’s journey. As a foun...

We invest in Fintech, Consumer Goods, B2B, Health, AI

We invest in Deeptech, Hardware, Software

We invest in fintech, ecommerce and payments

Battery's latest flagship fund..

We invest in for-profit enterprises with new products or business models that expand the range of high-quality financial services for underserved populations.

We invest in startups with $2M+ ARR

We invest in AI across medtech, proptech and fintech sectors.

We invest in IP-rich businesses, originating from or based in the North of England. We are focused on supporting visionary companies with strong intellectual property which have the ambition to positively change the world, particularly in the areas of deep technology and life sciences.

We invest in businesses across numerous industries in the US and emerging markets (most notably LATAM and Africa). We particularly focus on Fintech and general SaaS and look for companies with at least $250K in ARR (some exceptions).

We invest in fintech & insurtech with an emphasis on our ecosystem whereby portfolio companies will have partnering opportunities with banks & insurance companies that are LPs of Truffle funds

We invest in early-stage food ventures across the supply chain - both B2C & B2B - including high-growth consumer brands, next-gen commerce, digital technology, and proprietary foodtech. Our focus is Seed to Series A.

Energize's third fund..

We invest in enterprise software, marketplaces, and healthcare IT, but are technically industry agnostic. We invest in early revenue companies (post-revenue) up to $1M in ARR, primarily in the Southeastern US.

The Bertarelli family's (Serono pharma) investment office focusing on biotech and deep tech.

We invest in natural & organic consumer packaged goods brands and technology that help make the world better at every stage of their life cycle: Seed, Series A, Series B, and Growth.

We invest in emerging growth consumer brands

We invest in startups with at least one founder from the TU Delft, Erasmus University Rotterdam or the Erasmus MC.

Wamda's third MENA fund..

We invest in seed, seed extension and Series A staged real estate tech and construction tech companies.

We invest in UK based companies across almost all sectors and with each investment we look to coinvest with alongside sector smart angel investors.

I invest in startups connected to DAO in Blockchain with technology connected to smart contract and smart invest.

We invest in US eCommerce companies with social impact

We invest mostly in VC funds, but also do co-investments directly in companies at growth stage.

I invest in early stage startups, in any sector. I prefer subscription based business models.

I invest in innovative early-stage and Series A technology companies with strong growth potential. Focus areas: UK, DACH, USA, Dubai; AI, ML, blockchain, IoT, clean tech; B2B SaaS, marketplaces, deep tech. Seeking visionary founders, diverse teams, and clear paths to profitability. Cheque sizes: 200k-5M. 10x return potential within 5-7 years pref

We invest in: Agri, Food, Healthcare, Mobility, Education, Manufacturing, AI, Web3

We invest in hard tech and research spinouts.

We invest in early-stage tech startups based in North Carolina (USA), making <$1m ARR. We invest angel-sized checks in companies with a small amount of early traction.

We invest in a healthy mix of D2C, B2B, SaaS, and product startups in early stages founded by commercially-minded diverse founders with a growth mindset. Ventures II is a sector-agnostic fund. Our Fintech Fund is currently in the deployment phase and focused on Fintech B2B infrastructure.

We invest in companies with a strong competitive advantage, scalable and validated business model. B2B SaaS, Fintech, Blockchain, AI, crypto, Web3.

We invest in B2B tech, Energy, Renewables, Water, Agtech and Fintech sector businesses in the pre to early growth phase with low to no product risk.

I invest in anything as long as there is opportunity. Basically industry agnostic & country agnostic, have experience in looking into different stages; personally prone to disruptive stuff, but will not limit to anything.

We invest in emerging markets startups.

We invest in Healthcare (Medtech or Biotech), Proptech and Fintech companies with at least 40k€ MRR (excl. Biotech).

We invest in growth sectors: life-sciences, smart living and Tech. These sectors were chosen for their ability to generate the most value out of our regions. We invest local ventures in order to have a pro-active interaction with the entrepreneur and his venture. Our target are